Search and Find
Service
Cover
1
Contents
4
Contributors
8
Preface: Circles in drug research
9
Chapter 1. Stereochemical Aspects of Drug Action and Disposition
12
1 Introduction
13
2 Stereoselectivity in Drug Action
14
3 Stereoselectivity in Drug Disposition
25
4 Stereoselectivity and Toxicity
53
5 Implications and Consequences
54
6 Drug Development
62
7 Conclusion
65
References
66
Chapter 2. Advances in the Development of Pharmaceutical Antioxidants
76
1 Introduction
78
2 Endogenous Defence Systems
89
3 Semisynthetic Analogues of Endogenous Antioxidants
96
4 Natural Products
103
5 Synthetic Antioxidants
121
6 Clinical Agents
151
7 Conclusions
174
Acknowledgements
176
References
176
Chapter 3. Multidrug Resistance of Cancer Cells
192
1 Introduction and Overview
193
2 MDR1 and Clinical Multidrug Resistance
196
3 Mechanism of Action of the MDR1 Gene Product
208
4 MDR1 Gene Regulation
230
5 Other Mechanisms of Multidrug Resistance
237
6 Prospects for Pgp-related Chemotherapy
243
Acknowledgements
248
References
249
Chapter 4. Bioactivation of Organic Nitrates and Other Nitrovasodilators
264
1 Introduction
264
2 Nitric Oxide and Cyclic GMP as Meditiaiors of Organic Nitrate Action
265
3 Nitric Oxide Formation from Organic Nitrates in Cell-free Systems
265
4 Cytochrome P450 as a Mediator of Nitric Oxide Formation from Organic Nitrates in Intact Cells
268
5 Unanswered Questions
271
6 Outlook
274
References
275
Chapter 5. The Vitamin D Endocrine System and its Therapeutic Potential
280
1 Historical Introduction
281
2 Biosynthesis of Vitamin D
283
3 Metabolism of Vitamin D
284
4 Mechanism of Action of 1,25-(OH)2D3
291
5 Functions of Vitamin D
297
6 Regulation of the Vitamin D Endocrine System
303
7 Therapeutic Uses of Vitamin D Metabolites and Analogues
305
8 Conclusions and Future Directions
312
Acknowledgements
313
References
313
Chapter 6. Dopamine Receptors : Studies on Structure and Function
324
1 Multiple Dopamine Receptors
326
2 Common Properties of Dopamine Receptor Subtypes Defined by Molecular Biology
326
3 Distinct Properties of the Dopamine Receptor Subtypes Defined by Molecular Biological Techniques
331
4 The Mechanism of Binding of Ligands to Dopamine Receptors
337
5 Conclusions
357
References
358
Subject Index
364
Cumulative Index of Authors
378
Cumulative Index of Titles
382
All prices incl. VAT